RMTI Rockwell Medical Inc.

4.53
-0.22  -5%
Previous Close 4.75
Open 4.75
Price To Book 9.44
Market Cap 258655421
Shares 57,098,327
Volume 71,619
Short Ratio
Av. Daily Volume 373,528

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Anemia
NDA filing due 2Q 2019.
IV Triferic
Anemia

Latest News

  1. Rockwell Medical, Inc. to Present at H.C Wainwright Global Life Sciences Conference
  2. Edited Transcript of RMTI earnings conference call or presentation 14-Mar-19 12:30pm GMT
  3. Rockwell Medical, Inc. to Present at Sidoti & Company LLC Spring 2019 Investor Conference
  4. Rockwell Medical Announces I.V. Triferic® and Peritoneal Dialysis Study Abstracts Selected as Best-in-Category at the Annual Dialysis Conference
  5. Rockwell Medical: 4Q Earnings Snapshot
  6. Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
  7. Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019
  8. Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
  9. Rockwell Medical, Inc. (NASDAQ:RMTI): What Does Its Beta Value Mean For Your Portfolio?
  10. The Zacks Analyst Blog Highlights: Barclays, Rockwell Medical, NextEra, Belmond and Shaw Communications
  11. 7 Hot Momentum Stocks to Watch in 2019
  12. Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019
  13. Edited Transcript of RMTI earnings conference call or presentation 9-Nov-18 1:30pm GMT
  14. 5 Beaten-Down Medical Product Stocks to Rebound in 2019
  15. Report: Developing Opportunities within Eaton Vance, IDT, Hemispherx BioPharma, Edgewell Personal Care, Rockwell Medical, and Avadel Pharmaceuticals — Future Expectations, Projections Moving into 2018
  16. Rockwell Medical, Inc. Appoints New Vice President, Operations
  17. Rockwell Medical, Inc. Appoints New Vice President, Marketing
  18. Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates